Registry for Vascular Anomalies Associated With Coagulopathy (VAC)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
PURPOSE The purpose of this study is to learn more about multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). MLT is a rare vascular disorder characterized by multiple congenital skin and visceral lesions, profound thrombocytopenia, and gastrointestinal bleeding. The skin lesions may appear red, brown or blue, often misdiagnosed as hemangiomas. The gastrointestinal tract, liver, and lungs are the most common internal organs involved. The severe thrombocytopenia (low platelets) is believed to be the result of platelet trapping within the skin and visceral vascular lesions. Severe and chronic gastrointestinal bleeding is common during infancy and early childhood. Although a relatively newly described entity, MLT was likely previously reported as hemangiomas, blue rubber bleb nevus syndrome, diffuse hemangiomatosis, Kasabach-Merritt phenomenon, and hereditary hemorrhagic telangiectasia. The term cutaneovisceral angiomatosis with thrombocytopenia is also a term used for this same disease. This study is a longitudinal cohort study of MLT to collect detailed clinical data on the distribution of disease, disease severity, and complications. This data will be used to create diagnostic criteria and an evaluation protocol for infants with this disease
| Condition | Intervention |
|---|---|
|
Multifocal Lymphangioendotheliomatosis With Thrombocytopenia Cutaneovisceral Angiomatosis With Thrombocytopenia Vascular Anomaly With Thrombocytopenia Hemangiomas |
Other: no intervention |
| Study Type: | Observational |
| Official Title: | International Registry for Vascular Anomalies Associated With Coagulopathy |
Buccal swab, tissue biopsy if available
| Estimated Enrollment: | 30 |
| Study Start Date: | November 2007 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Vascular Anomaly with Coagulopathy
All patients diagnosed with Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT) or with a vascular anomaly with coagulopathy
|
Other: no intervention
no intervention - observational only
|
Detailed Description:
After informed consent is obtained a detailed question will be mailed to participating patients and families. This questionnaire will also be available electronically through an educational website. Data collected will include photographs of skin lesions, video images of gastrointestinal lesions, demographic data, clinical information, therapeutic interventions, glass slides of tissue biopsies, and collection of DNA. Enrollment will be patient family driven and modeled after several successful registries of rare diseases.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
All patients diagnosed with Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT) or with a vascular anomaly with coagulopathy
Inclusion Criteria:
- Subjects with a vascular anomaly with coagulopathy
Exclusion Criteria:
- Subjects without a vascular anomaly with coagulopathy
Contacts and Locations| Contact: Kelly J Duffy, PhD | (414) 955-4078 | kduffy@mcw.edu |
| United States, Wisconsin | |
| Medical College of Wisconsin | Recruiting |
| Milwaukee, Wisconsin, United States, 53226 | |
| Contact: Kelly J Duffy, PhD 414-955-4078 kduffy@mcw.edu | |
| Principal Investigator: | Beth Drolet, MD | Medical College of Wisconsin |
| Principal Investigator: | Ulrich Broeckel, MD | Medical College of Wisconsin |
| Principal Investigator: | Howard Jacob, PhD | Medical College of Wisconsin |
| Principal Investigator: | Michael Kelly, MD, PhD | Medical College of Wisconsin |
| Principal Investigator: | Richard Noel, MD, PhD | Medical College of Wisconsin |
| Principal Investigator: | Paula North, MD, PhD | Medical College of Wisconsin |
| Principal Investigator: | Kelly Duffy, PhD | Medical College of Wisconsin |
More Information
Additional Information:
No publications provided
| Responsible Party: | Beth Drolet, Professor of Dermatology and Pediatrics, Medical College of Wisconsin |
| ClinicalTrials.gov Identifier: | NCT00576888 History of Changes |
| Other Study ID Numbers: | CHW07/226, GC567 |
| Study First Received: | December 18, 2007 |
| Last Updated: | January 23, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Medical College of Wisconsin:
|
Multifocal lymphangioendoltheliomatosis with thrombocytopenia Cutaneovisceral angiomatosis with thrombocytopenia Thrombocytopenia Hemangiomas Hemangiomatosis |
Lymphatic malformation Kasabach-Merritt Blue-rubber bleb nevus Angiomatosis |
Additional relevant MeSH terms:
|
Congenital Abnormalities Angiomatosis Blood Coagulation Disorders Hemostatic Disorders Hemangioma Thrombocytopenia Vascular Malformations Vascular Diseases |
Cardiovascular Diseases Hematologic Diseases Hemorrhagic Disorders Neoplasms, Vascular Tissue Neoplasms by Histologic Type Neoplasms Blood Platelet Disorders Cardiovascular Abnormalities |
ClinicalTrials.gov processed this record on June 18, 2013